title: Improvement of polymorphonuclear functions in dialysed patients treated with recombinant human erythropoietin need not to be dependent on serum ferritin decrease.
authors.forename: S
authors.initials: S
authors.lastname: Sulková
authors.forename: J
authors.initials: J
authors.lastname: Bartůnková
authors.forename: T
authors.initials: T
authors.lastname: Fucíková
authors.forename: J
authors.initials: J
authors.lastname: Bláha
authors.forename: A
authors.initials: A
authors.lastname: Válek
mesh_terms: D002176:Candida albicans / Q000276:immunology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004921:Erythropoietin / Q000627:therapeutic use*; D005293:Ferritins / Q000097:blood; D006801:Humans; D066298:In Vitro Techniques; D009504:Neutrophils / Q000187:drug effects* / Q000276:immunology; D006435:Renal Dialysis
chemical_list: D004921:Erythropoietin; D005293:Ferritins